新聞

HERON Collaborates with TVGH to Advance Clinical Research of AB-BNCT in First-Line Treatment for Head and Neck Cancer

Heron Neutron Medical Corp. and TVGH launch a clinical study exploring AB-BNCT as a first-line treatment strategy for head and neck cancer.

Heron Neutron Medical Corp. Submits Medical Device Registration for “Bennu” AB-BNCT Neutron Irradiation System to Singapore HSA

Heron Neutron Medical Corp. has officially submitted the medical device registration application for its self-developed “Bennu” AB-BNCT neutron irradiation system to Singapore’s Health Sciences Authority (HSA), marking a key milestone toward regulatory review and clinical implementation of the first AB-BNCT system in Southeast Asia, in collaboration with NUS medical institutions and A*STAR.

Heron Neutron Medical Corp. Launches International 18F-FBPA Research Collaboration with NUS Medicine

Heron Neutron Medical Corp. Receives TFDA Approval for BNCT Treatment Planning System

Heron Neutron Medical Corp. Advances Neutron Irradiation System TFDA Approval Now Covers BNCT Treatment Planning System, Completing the Precision Medicine Ecosystem